Adozelesin, a potent new alkylating agent: cell-killing kinetics and cell-cycle effects
β Scribed by Bijoy K. Bhuyan; Kathy S. Smith; Earl G. Adams; Tanya L. Wallace; Daniel D. Hoff; Li H. Li
- Publisher
- Springer
- Year
- 1992
- Tongue
- English
- Weight
- 801 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background: Paclitaxel (Taxol) is known to act mainly in mitosis, interfering with microtubule dynamics, but effects on the other cells cycle phases have been reported also. However, a comparative picture of perturbation and killing in the G 1 , S and G 2 M phases after drug treatment is lacking. Th
The efficacy of killing small cell lung cancer (SCLC) cells at the G I , S, and G2-M phase of the cell-cycle by a new "'In-bleomycin complex (' ' 'In-BLMC) was investigated. SCLC cells (N417, H526, H209) were synchronized by double thymidine block and assessed by DNA content with flow cytometry, and
We have investigated the effects on Succliaronijxes cerevisirie of a novel antitumour agent (FCE245 17 or Tallimustine) which causes selective alkylations to adenines in the minor groove of DNA. Tallimustine, added to wild-type cells for short periods, reduced the growth rate and increased the perce
The replication of several human and animal cancer cell lines is regulated in vitro and in vivo by 1,25-dihydroxyvitamin D3 I 1 ,25-(OH),D3], the hormonally active form of vitamin Uj. We have examined the effects of concentrations of 1 ,25-(OH)2D3, which inhibit cellular replication, on the cell-cyc